Shadow Rider Calyrex VMAX #TG30

Astral Radiance Trainer Gallery was released in 2022. It belongs to the Sword & Shield series.

With 30 listed cards, this is a compact set by modern TCG standards. As of 2026, the set is 4 years old and sits in a modern-era collecting window.

In the Astral Radiance Trainer Gallery checklist, Shadow Rider Calyrex VMAX occupies position #TG30 as a Rare Secret card.

In 2022, Astral Radiance Trainer Gallery introduced this print of Shadow Rider Calyrex VMAX. Core profile: Its card type is Pokémon.

The rarity label is Rare Secret. Printed HP is 320.

Energy typing is Psychic. Shadow Rider Calyrex VMAX evolves from Shadow Rider Calyrex V.

Card rules text: VMAX rule: When your Pokémon VMAX is Knocked Out, your opponent takes 3 Prize cards. Printed ability include "Underworld Door".

Shadow Rider Calyrex VMAX (Astral Radiance Trainer Gallery) is presently valued at about $4.08 in raw condition. Price action is stable over 7 days, moving only +1.8%.

Current value is elevated versus the 30-day mean ($3.77), by 8.3%. In the past 90 days, observed prices ranged from $3.16 to $4.25 (27% spread), a moderate-volatility profile.

Rarity classification for this copy is Rare Secret.

Other Shadow printings create a useful comparison set for Shadow Rider Calyrex VMAX. This comparison sample includes 4 alternatives across 2 sets.

In this sample, pricing ranges between $1.55 and $69.62 (4392% total span). Relative to the alternative average ($22.32), this card is -82%.

Notable alternatives include Shadow Rider Calyrex VMAX #75 (Chilling Reign) at $1.55, Shadow Rider Calyrex VMAX #204 (Chilling Reign) at $8.12, Shadow Rider Calyrex VMAX #205 (Chilling Reign) at $69.62, and Shadow Rider Calyrex VMAX #TG18 (Astral Radiance Trainer Gallery) at $9.98.

Pricing context for collectors: Short-term movement is stable (+1.8% over 7 days), with price action clustered near recent averages. Observed 90-day bounds of $3.16 and $4.25 create a 27% band, matching a moderate-volatility profile.

Current value is 8.3% above its 30-day reference ($3.77). Graded context points to a substantial premium curve, with PSA 10 at +597% above raw pricing.

PSA 9 is currently around $14.53, while PSA 10 is $28.45.